Hareer Fatima
Overview
Explore the profile of Hareer Fatima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rangwala H, Fatima H, Syed A, Abbas S, Rangwala B
Ann Neurosci
. 2025 Feb;
32(1):51-57.
PMID: 40017568
Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons, resulting in motor symptoms. Ongoing research shows promise for long-term solutions. Summary: Studies highlight...
2.
Furqan M, Raza I, Younus S, Fatima H, Azhar H, Fatima S, et al.
Egypt Heart J
. 2025 Feb;
77(1):18.
PMID: 39899186
Background: Over the past fifty years, the incidence of atrial fibrillation (AF) has tripled. Traditionally, the main treatment for this condition has been pulmonary vein isolation (PVI) performed using radiofrequency...
3.
Waheed Y, Rangwala H, Fatima H, Riaz F, Mubarak F
Ann Neurosci
. 2025 Jan;
31(4):250-257.
PMID: 39840142
Background: Hyperdense middle cerebral artery sign (HMCAS) on a non-enhanced multidetector computed tomography (MDCT) scan is considered an important radiological marker in detecting acute arterial thrombotic occlusion, and it is...
4.
Fatima H, Rangwala H, Mustafa M, Shafique M, Abbas S, Rangwala B
Ther Adv Endocrinol Metab
. 2024 Sep;
15:20420188241274310.
PMID: 39234426
Background: Non-alcoholic fatty liver disease (NAFLD) is a common liver condition affecting 25%-40% of the worldwide population. NAFLD is traditionally related to obesity and metabolic disorders. NAFLD can also affect...
5.
Rangwala B, Shakil A, Mustafa M, Rangwala H, Fatima H, Siddiq M
Ann Neurosci
. 2024 Aug;
31(3):152-154.
PMID: 39156623
No abstract available.
6.
Raza I, Younus S, Azhar H, Fatima H, Anwar Z, Farah A, et al.
Ann Med Surg (Lond)
. 2024 Jul;
86(7):3824-3826.
PMID: 38989231
No abstract available.
7.
Rangwala H, Fatima H, Ali M, Mustafa M, Shafique M, Rangwala B, et al.
J Diabetes Metab Disord
. 2024 Jun;
23(1):1199-1222.
PMID: 38932909
Purpose: Excess body fat, insulin resistance, and abnormal lipid levels signal type 2 diabetes mellitus (DM2). Globally, 536.6 million people suffer from DM2, projected to rise to 783.2 million by...
8.
Rangwala H, Fatima H, Ali M, Shafiq M, Rangwala B, Virwani V, et al.
Am J Cardiovasc Drugs
. 2024 May;
24(4):523-535.
PMID: 38713309
Background: Cardiovascular disease remains a significant global health concern, with high low-density lipoprotein cholesterol (LDL-C) levels contributing to an increased risk. Familial hypercholesterolemia (FH) further complicates its management, necessitating additional...
9.
Rangwala H, Fatima H, Ali M, Sunder S, Devi S, Rangwala B, et al.
J Egypt Natl Canc Inst
. 2024 May;
36(1):14.
PMID: 38705953
Background: Nivolumab (Nivo) and ipilimumab (Ipi) have revolutionized cancer treatment by targeting different pathways. Their combination shows promising results in various cancers, including melanoma, but not all studies have demonstrated...
10.
Fatima H, Riaz F, Mustafa M, Rangwala B, Abbas S, Rangwala H
Ann Neurosci
. 2024 May;
31(2):80-82.
PMID: 38694714
No abstract available.